So far I have just found a negative study? esp. the most recent article from American journal of transplantation this year? So is this the end? or is Rituximab good only for sensitized or ABO incompatible? Have you a good profile for it?
Can I suggest the Systematic Review recently published by Macklin et al in Transplantation Reviews. They looked specifically at this population, and in very brief summary the answer is no...
Dear dr O'Callaghan, is the same paper I have already suggested and sent dr. Cheungpasitporn : I think that for dr Cheungpasitporn studies might be interesting this new study I am now encloding,
Thank you very much, Dr.O'Callaghan and again, Prof. Salvadori. These 2 review papers are very helpful! I understand much better in the use of RTX for both sensitized and non-sensitized settings!